Breeding and caring for rhesus macaques used in HIV/AIDS research
Official title: Animal Husbandry Core
Funded at Texas Biomedical Research Institute · NIH-11325734 · Data updated 2026-11-12
This project breeds and cares for healthy, well‑characterized rhesus macaques so researchers can develop better HIV/AIDS vaccines and treatments for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Biomedical Research Institute NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | September 30, 2000 |
| Project end | January 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $2,055,915 |
| NIH project number | 5U42OD010442-25 |
| Project ID | NIH-11325734 on NIH RePORTER |
Who could benefit from this research
✓Could help
This project does not enroll patients; it is an animal resource that supports researchers working on HIV/AIDS.
✕Less likely to help
Patients with health issues unrelated to HIV/AIDS are unlikely to receive any direct benefit from this breeding and husbandry program.
What this research studies
This project expands and manages a colony of Indian‑origin, specific‑pathogen‑free rhesus macaques prioritized for HIV/AIDS research. Staff use genetic typing, behavioral and demographic monitoring, and reproductive management to maximize genetic diversity and production efficiency. The team plans to grow the colony toward about 1,000 animals and make roughly 150 macaques available annually for approved AIDS-related studies. These animals and their associated data support testing of vaccines, therapies, and other biomedical work aimed at helping people with HIV.
Why it matters
Potential benefit: If successful, a steady supply of well‑characterized macaques could speed development and testing of HIV vaccines and treatments that benefit people living with HIV.
How similar studies have gone: Rhesus macaque colonies have long been essential and successful in advancing HIV/AIDS vaccines and therapies, so this is an established approach rather than an untested idea.
Where this research is happening
-
Texas Biomedical Research Institute
San Antonio, United States Active
Researchers
- Principal investigator: Kaushal, Deepak — Texas Biomedical Research Institute
- Study coordinator: Kaushal, Deepak
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.